High levels of serum (exceeding the cut-off values) of CEA, CA15-3, and CA125 were determined in 48 (4.99%), 54 (5.62%), and 55 (5.72%) breast cancer patients, respectively. Here, CEACAM5 is linked to breast carcinoma.